Cognition Therapeutics In...

NASDAQ: CGTX · Real-Time Price · USD
1.54
-0.12 (-7.23%)
At close: Aug 15, 2025, 3:59 PM
1.57
1.62%
After-hours: Aug 15, 2025, 07:56 PM EDT

Cognition Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
25.01M 29.92M 41.56M 54.72M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a 1.73M n/a
Receivables
2.69M 1.28M 3.67M 2.27M
Inventory
n/a n/a n/a 1.99M
Other Current Assets
n/a n/a n/a -1.98M
Total Current Assets
29.55M 34.22M 47.65M 58.99M
Property-Plant & Equipment
679K 941K 1.05M 145K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
679K 941K 2.78M 145K
Total Assets
30.23M 35.16M 50.42M 59.14M
Account Payables
1.98M 3.69M 3.22M 4.17M
Deferred Revenue
1.07M 1.7M 1.7M 753K
Short-Term Debt
279K 544K 634K n/a
Other Current Liabilities
1.53M 2.89M 870K 1.19M
Total Current Liabilities
11.14M 10.17M 7.79M 7.86M
Long-Term Debt
n/a 520K n/a n/a
Other Long-Term Liabilities
n/a -520K 695K n/a
Total Long-Term Liabilities
342K 520K 2.38M 4.17M
Total Liabilities
11.48M 10.69M 10.18M 7.86M
Total Debt
814K 1.24M 1.48M n/a
Common Stock
60K 32K 29K 22K
Retained Earnings
-175.16M -141.19M -115.4M -94M
Comprehensive Income
n/a -195K -199K -198K
Shareholders Equity
18.75M 24.47M 40.25M 51.27M
Total Investments
n/a n/a n/a n/a